Popular
IRB: Patient Protection in Clinical Research
from Medical Development Group (MDG)
This event has passed.
Wednesday, May 28, 2008, 5:30pm - 8:00pm
Federal law mandates that research involving human subjects be approved and supervised by a Institutional Review Board - IRB - in order to:
* Protect the rights and welfare of human research subjects;
* Protect human subjects from undue research risks;
* Protect human subjects from invasion of privacy; and
* Promote scientifically sound, ethical research of the potential risks and safeguards as well as the benefits.
While IRB submissions and approvals are frequently viewed as necessary impediments to the initiation of a clinical trial, the IRB can in fact be an important contributor to trial management and completion. James Saunders, Vice President of New England Institutional Review Board, a leading independent (not affiliated with a specific research institution) IRB, will provide his perspective on the role and priorities of the IRB, and how trial sponsors can most effectively work with the IRB to assure a successful trial.
Speaker:
James Saunders, Vice President, New England Institutional Review Board (NEIRB)
More information...
Pingbacks ( Use this URL to link to this event: http://www.marksguide.com/event/820/ )
